Open AccessSphingomonas paucimobilis an unusual cause of subdural empyema in pediatric: a case report
Author(s) -
Annisa Muhyi,
Amalia Aswin
Publication year - 2022
Publication title -
pediatrics sciences journal
Language(s) - English
Resource type - Journals
eISSN - 2722-1474
pISSN - 2722-0427
DOI - 10.51559/pedscij.v2i1.19
Subject(s) - medicine , leukocytosis , subdural empyema , sphingomonas paucimobilis , meropenem , levofloxacin , moxalactam , cerebrospinal fluid , meningitis , empyema , white blood cell , absolute neutrophil count , latamoxef , gastroenterology , amikacin , cephalosporin , surgery , anesthesia , antibiotics , microbiology and biotechnology , chemotherapy , antibiotic resistance , biology , bacteria , neutropenia , genetics
Acute bacterial meningitis continues to be a neurological emergency with high mortality and morbidity
Case: We report the case of a pediatric patient with subdural empyema due to Sphingomonas paucimobilis. A 2-month-old infant developed fever, generalized seizures, and worsening general status. He had a cough for two weeks, and a chest X-ray showed pneumonia. Laboratory tests reveal marked leukocytosis, a white blood cell count of 28.500/mL, and an elevated platelet level of 654.000 mg/dL. A computerized brain tomography revealed an empyema subdural. A cerebrospinal fluid analysis showed unclear fluid, revealed cell count 3560 cells, 90% mononuclear and 10% polymorphonuclear, red blood cell count of 0/mm3, protein of 370 mg/dL, and glucose of 35 mg/dL. His cerebrospinal fluid culture showed Sphingomonas paucimobilis sensitive to cephalosporin, levofloxacin, meropenem, imipenem, gentamycin, tobramycin and amikacin. He was treated empirically with meropenem. The patient had a rapid recovery from the seventh day of treatment and was discharged on hospital day 14.
Conclusion: We highly recommend raising awareness about subdural empyema as a complication for acute bacterial meningitis caused by S. paucimobilis in community-acquired infection.